HIV Seropositivity: all 215 studies
Page 3 of 3. Open to participants first (10), then studies with results posted, then the rest; newest registration first within each.
- A Phase I Study of the Safety of Proleukin (Aldesleukin) in Combination With Ganciclovir and Antiretroviral Therapy in HIV Seropositive Patients With Cytomegalovirus (CMV) RetinitisCompletedNCT00002321Phase 1
- A Study to Evaluate the Safety and Effectiveness of a New Non-Nucleoside Reverse Transcriptase Inhibitor (NNRTI), (+)-Calanolide A, in HIV-Positive Patients Who Have Never Received Anti-HIV TreatmentCompletedNCT00002243Phase 1
- A Study of Viracept in HIV-Positive WomenCompletedNCT00002171Phase 2
- Phase II/III Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive PatientsStatus unknownNCT00002099Phase 2
- Phase I/II Study of the Tolerance and Efficacy of Combined Use of Didanosine (2',3'-Dideoxyinosine; ddI) and Lentinan in HIV-Positive PatientsCompletedNCT00002098Phase 1
- A Third-Party Blinded, Placebo Controlled Comparative Study of AS-101 Administered Intravenously in HIV Positive Patients With Advanced DiseaseCompletedNCT00002033Not applicable
- Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic IndividualsCompletedNCT00001997Not applicable
- Pharmacodynamics of Intermittent IL-2 Infusions in HIV Seropositive PatientsCompletedNCT00001474Phase 2
- The Effect of Anti-HIV Therapy on Fat Metabolism in HIV-Positive PatientsCompletedNCT00001102
- A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive IndividualsCompletedNCT00000772Phase 1
- A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARCCompletedNCT00000735Phase 1
- A Phase I/II Dose Escalation Study of Intradermal gp160 to Evaluate Safety, Delayed Type Hypersensitivity (Skin Test) Responses and Immunogenicity in Asymptomatic HIV Seropositive Patients With More Than 400 CD4+ CellsCompletedNCT00000667Phase 1
- Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine in HIV Positive, Asymptomatic and Symptomatic IndividualsCompletedNCT00000664Phase 1
- A Pilot Study Evaluating Penicillin G and Ceftriaxone as Therapies for Presumed Neurosyphilis in HIV Seropositive IndividualsCompletedNCT00000648Not applicable
- A Phase I Multicenter Clinical Trial to Evaluate the Safety and Immunogenicity of Immuno-AG Recombinant HIV gp160 in Asymptomatic HIV Seropositive IndividualsCompletedNCT00000633Phase 1